BHCM
CRMD icon

Brevan Howard Capital Management’s CorMedix CRMD Stock Holding History

Brevan Howard Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
36,316
-3,713
-9% -$29.3K ﹤0.01% 1740
2026
Q1 		$272K Sell
40,029
-27,805
-41% -$206K ﹤0.01% 1686
2025
Q4 		$789K Sell
67,834
-78,655
-54% -$870K 0.01% 880
2025
Q3 		$1.7M Buy
146,489
+126,785
+643% +$1.53M 0.01% 637
2025
Q2 		$243K Buy
+19,704
New +$218K ﹤0.01% 1630

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Brevan Howard Capital Management's CRMD Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its CorMedix (CRMD) stake by 9.3% in Q2 2026, selling an estimated $29.3K and leaving 36,316 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Brevan Howard Capital Management first reported a position in CRMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.7M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Brevan Howard Capital Management held 36,316 shares of CorMedix worth $285K as of Q2 2026.
  • Brevan Howard Capital Management sold 3,713 CorMedix shares in Q2 2026, an estimated $29.3K.
  • CorMedix made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1740 holding.
  • Brevan Howard Capital Management first reported a position in CorMedix in Q2 2025 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's CorMedix position peaked at $1.7M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.